SLS Stock-Based Compensation
Sellas Life Sciences Group Inc · Stock-Based Compensation
SLS Stock-Based Compensation
Latest reported$1.02Mperiod ending
SLS Quarterly Stock-Based Comp ($0.00 → $1.02M)
Quarterly stock-based compensation
High-resolution chart · PNG
SLS stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 1,015,000 | |
| 798,000 | |
| 447,000 | |
| 503,000 | |
| 501,000 | |
| 505,000 | |
| 373,000 | |
| 381,000 | |
| 334,000 | |
| 476,000 | |
| 497,000 | |
| 543,000 | |
| 514,000 | |
| 540,000 | |
| 446,000 | |
| 455,000 | |
| 450,000 | |
| 375,000 | |
| 288,000 | |
| 275,000 | |
| 264,000 | |
| 184,000 | |
| 141,000 | |
| 146,000 | |
| 146,000 | |
| 145,000 | |
| 147,000 | |
| 115,000 | |
| 126,000 | |
| 185,000 | |
| 111,000 | |
| 137,000 | |
| 125,000 | |
| 22,000 | |
| 2,593,000 | |
| 151,000 | |
| 197,000 | |
| 228,000 | |
| 434,000 | |
| 552,000 | |
| 622,000 | |
| 656,000 | |
| 597,000 | |
| 62,000 | |
| 645,000 | |
| 627,000 | |
| 952,000 | |
| 1,299,000 | |
| 1,513,000 | |
| 1,623,000 | |
| 1,186,000 | |
| 729,000 | |
| 367,000 | |
| 248,000 | |
| 593,000 | |
| 180,000 | |
| 194,000 | |
| 427,000 | |
| 200,000 | |
| 991,000 | |
| 496,000 | |
| 1,314,000 | |
| 910,000 | |
| 833,000 | |
| 1,426,000 | |
| 1,199,000 | |
| 1,150,000 | |
| 652,000 | |
| 1,741,000 | |
| 659,000 | |
| 0 | |
| 0 | |
| 1,885,000 | |
| 629,000 | |
| 0 | |
| 436,000 | |
| 1,341,000 | |
| 0 | |
| 0 |